ALK |
Q9UM73
|
ALK receptor tyrosine kinase
|
Kinase
|
3.2E-06 |
0.396 |
0.846 |
APC |
P25054
|
APC regulator of WNT signaling pathway
|
|
1.00 |
0.373 |
0.962 |
ARID1A |
O14497
|
AT-rich interaction domain 1A
|
|
1.00 |
0.455 |
0.846 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDX2 |
Q99626
|
caudal type homeobox 2
|
Transcription factor
|
0.53 |
0.458 |
0.769 |
CEACAM3 |
P40198
|
CEA cell adhesion molecule 3
|
|
1.1E-09 |
0.494 |
0.731 |
CEACAM5 |
P06731
|
CEA cell adhesion molecule 5
|
|
4.2E-10 |
0.420 |
0.846 |
CEACAM7 |
Q14002
|
CEA cell adhesion molecule 7
|
|
1.3E-07 |
0.494 |
0.769 |
CHEK2 |
O96017
|
checkpoint kinase 2
|
Kinase
|
1.2E-24 |
0.460 |
0.808 |
DCC |
P43146
|
DCC netrin 1 receptor
|
|
0.99 |
0.471 |
0.808 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
EPCAM |
P16422
|
epithelial cell adhesion molecule
|
|
1.3E-07 |
0.451 |
0.885 |
ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
ETS1 |
P14921
|
ETS proto-oncogene 1, transcription factor
|
Transcription factor
|
0.78 |
0.444 |
0.731 |
H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
IGF1 |
P05019
|
insulin like growth factor 1
|
|
0.27 |
0.318 |
0.885 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
MAP2K7 |
O14733
|
mitogen-activated protein kinase kinase 7
|
Kinase
|
1.00 |
0.419 |
0.808 |
MDM2 |
Q00987
|
MDM2 proto-oncogene
|
Nucleic acid binding
|
1.00 |
0.362 |
0.846 |